StockData
Oncolytics Biotech Inc logo

Oncolytics Biotech Inc (ONCY) stock

ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.44+0.06 (+15.11%)

Close on Nov 18, 2026Market cap $56.14MP/E –Yield –

Oncolytics Biotech operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2024 it was -C$34.98M. The highest annual figure on record is -C$13.92M in fiscal 2015.

Annual operating income

PeriodPeriod endValueChange
FY2024Dec 31, 2024-C$34.98M–
FY2023Dec 31, 2023-C$33.79M–
FY2022Dec 31, 2022-C$26.92M–
FY2021Dec 31, 2021-C$26.24M–
FY2020Dec 31, 2020-C$25.46M–
FY2019Dec 31, 2019-C$20.38M–
FY2018Dec 31, 2018-C$17.27M–
FY2017Dec 31, 2017-C$15.61M–
FY2016Dec 31, 2016-C$15.29M–
FY2015Dec 31, 2015-C$13.92M–

More Oncolytics Biotech figures

See a number that looks wrong?